Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ASP Isotopes (ASPI) EBITDA (2022 - 2025)

ASP Isotopes has reported EBITDA over the past 4 years, most recently at -$77.3 million for Q4 2025.

  • For Q4 2025, EBITDA fell 551.54% year-over-year to -$77.3 million; the TTM value through Dec 2025 reached -$170.8 million, down 408.45%, while the annual FY2025 figure was -$170.8 million, 409.12% down from the prior year.
  • EBITDA for Q4 2025 was -$77.3 million at ASP Isotopes, down from -$12.1 million in the prior quarter.
  • Over five years, EBITDA peaked at -$472642.0 in Q2 2022 and troughed at -$77.3 million in Q4 2025.
  • A 4-year average of -$14.2 million and a median of -$5.4 million in 2023 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: crashed 906.9% in 2023 and later increased 2.82% in 2025.
  • Year by year, EBITDA stood at -$1.3 million in 2022, then tumbled by 185.22% to -$3.8 million in 2023, then tumbled by 209.53% to -$11.9 million in 2024, then tumbled by 551.54% to -$77.3 million in 2025.
  • Business Quant data shows EBITDA for ASPI at -$77.3 million in Q4 2025, -$12.1 million in Q3 2025, and -$74.1 million in Q2 2025.